SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-23-045288
Filing Date
2023-12-18
Accepted
2023-12-18 16:56:45
Documents
5
Period of Report
2023-12-18

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 23878
2 ex5-1.htm EX-5.1 114349
3 ex5-1_001.jpg GRAPHIC 18286
4 ex5-1_002.jpg GRAPHIC 13318
5 ex10-1.htm EX-10.1 229287
  Complete submission text file 0001493152-23-045288.txt   412245
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-41386 | Film No.: 231494507
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)